Insmed Statistics

Share Statistics

Insmed has 189.95M shares outstanding. The number of shares has increased by 10.53% in one year.

Shares Outstanding	189.95M
Shares Change (YoY)	10.53%
Shares Change (QoQ)	4.95%
Owned by Institutions (%)	99.99%
Shares Floating	206.91M
Failed to Deliver (FTD) Shares	22,461
FTD / Avg. Volume	0.61%

Short Selling Information

The latest short interest is 9.69M, so 5.1% of the outstanding shares have been sold short.

Short Interest	9.69M
Short % of Shares Out	5.1%
Short % of Float	5.72%
Short Ratio (days to cover)	3.41

Valuation Ratios

The PE ratio is -12.39 and the forward PE ratio is -29.95. Insmed's PEG ratio is -2.88.

PE Ratio	-12.39
Forward PE	-29.95
PS Ratio	31.14
Forward PS	23.9
PB Ratio	39.69
P/FCF Ratio	-16.05
PEG Ratio	-2.88

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Insmed.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.45, with a Debt / Equity ratio of 4.59.

Current Ratio	5.45
Quick Ratio	5.12
Debt / Equity	4.59
Debt / EBITDA	-1.61
Debt / FCF	-1.86
Interest Coverage	-10.34

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$286.16K
Profits Per Employee	$-718.94K
Employee Count	1,271
Asset Turnover	0.18
Inventory Turnover	0.87

Taxes

Income Tax	3.71M
Effective Tax Rate	-0.41%

Stock Price Statistics

The stock price has increased by 52.34% in the last 52 weeks. The beta is 0.95, so Insmed's price volatility has been higher than the market average.

Beta	0.95
52-Week Price Change	52.34%
50-Day Moving Average	97.45
200-Day Moving Average	79.04
Relative Strength Index (RSI)	67
Average Volume (20 Days)	3,684,500

Income Statement

In the last 12 months, Insmed had revenue of 363.71M and earned -913.77M in profits. Earnings per share was -5.57.

Revenue	363.71M
Gross Profit	277.96M
Operating Income	-878.25M
Net Income	-913.77M
EBITDA	-814.14M
EBIT	-829.81M
Earnings Per Share (EPS)	-5.57

Full Income Statement

Balance Sheet

The company has 555.03M in cash and 1.31B in debt, giving a net cash position of -754.91M.

Cash & Cash Equivalents	555.03M
Total Debt	1.31B
Net Cash	-754.91M
Retained Earnings	-4.36B
Total Assets	2.48B
Working Capital	1.77B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -683.88M and capital expenditures -21.92M, giving a free cash flow of -705.8M.

Operating Cash Flow	-683.88M
Capital Expenditures	-21.92M
Free Cash Flow	-705.8M
FCF Per Share	-4.3

Full Cash Flow Statement

Margins

Gross margin is 76.43%, with operating and profit margins of -241.47% and -251.24%.

Gross Margin	76.43%
Operating Margin	-241.47%
Pretax Margin	-250.22%
Profit Margin	-251.24%
EBITDA Margin	-223.84%
EBIT Margin	-241.47%
FCF Margin	-194.06%

Dividends & Yields

INSM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for INSM is $110.5, which is -2.1% lower than the current price. The consensus rating is "Buy".

Price Target	$110.5
Price Target Difference	-2.1%
Analyst Consensus	Buy
Analyst Count	15

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on Mar 3, 2011. It was a backward split with a ratio of 1:10.

Last Split Date	Mar 3, 2011
Split Type	backward
Split Ratio	1:10

Scores

Altman Z-Score	7.04
Piotroski F-Score	3

Insmed (INSM)